240 related articles for article (PubMed ID: 36913130)
1. Immunoregulatory and/or Anti-inflammatory Agents for the Management of Core and Associated Symptoms in Individuals with Autism Spectrum Disorder: A Narrative Review of Randomized, Placebo-Controlled Trials.
Arteaga-Henríquez G; Gisbert L; Ramos-Quiroga JA
CNS Drugs; 2023 Mar; 37(3):215-229. PubMed ID: 36913130
[TBL] [Abstract][Full Text] [Related]
2. Omega-3 fatty acids supplementation for autism spectrum disorders (ASD).
James S; Montgomery P; Williams K
Cochrane Database Syst Rev; 2011 Nov; (11):CD007992. PubMed ID: 22071839
[TBL] [Abstract][Full Text] [Related]
3. Inflammation (IL-1β) Modifies the Effect of Vitamin D and Omega-3 Long Chain Polyunsaturated Fatty Acids on Core Symptoms of Autism Spectrum Disorder-An Exploratory Pilot Study
Mazahery H; Conlon CA; Beck KL; Mugridge O; Kruger MC; Stonehouse W; Camargo CA; Meyer BJ; Tsang B; von Hurst PR
Nutrients; 2020 Feb; 12(3):. PubMed ID: 32121236
[TBL] [Abstract][Full Text] [Related]
4. A randomised controlled trial of vitamin D and omega-3 long chain polyunsaturated fatty acids in the treatment of irritability and hyperactivity among children with autism spectrum disorder.
Mazahery H; Conlon CA; Beck KL; Mugridge O; Kruger MC; Stonehouse W; Camargo CA; Meyer BJ; Jones B; von Hurst PR
J Steroid Biochem Mol Biol; 2019 Mar; 187():9-16. PubMed ID: 30744880
[TBL] [Abstract][Full Text] [Related]
5. Antioxidant interventions in autism spectrum disorders: A meta-analysis.
Liu Y; Yang Z; Du Y; Shi S; Cheng Y
Prog Neuropsychopharmacol Biol Psychiatry; 2022 Mar; 113():110476. PubMed ID: 34793863
[TBL] [Abstract][Full Text] [Related]
6. Sulforaphane as an adjunctive treatment for irritability in children with autism spectrum disorder: A randomized, double-blind, placebo-controlled clinical trial.
Momtazmanesh S; Amirimoghaddam-Yazdi Z; Moghaddam HS; Mohammadi MR; Akhondzadeh S
Psychiatry Clin Neurosci; 2020 Jul; 74(7):398-405. PubMed ID: 32347624
[TBL] [Abstract][Full Text] [Related]
7. Emerging drugs for the treatment of irritability associated with autism spectrum disorder.
Shamabadi A; Karimi H; Arabzadeh Bahri R; Motavaselian M; Akhondzadeh S
Expert Opin Emerg Drugs; 2024 Mar; 29(1):45-56. PubMed ID: 38296815
[TBL] [Abstract][Full Text] [Related]
8. A randomised, double-blind, placebo-controlled trial of minocycline and/or omega-3 fatty acids added to treatment as usual for at-risk mental states (NAYAB): study protocol.
Qurashi I; Chaudhry IB; Khoso AB; Farooque S; Lane S; Husain MO; Chu S; Sarginson J; Hamarani M; Naqvi HA; Razzaque B; Minhas FA; Yung AR; Deakin JFW; Husain N
Trials; 2017 Nov; 18(1):524. PubMed ID: 29121974
[TBL] [Abstract][Full Text] [Related]
9. Immunological Dysfunction in Autism Spectrum Disorder: A Potential Target for Therapy.
Marchezan J; Winkler Dos Santos EGA; Deckmann I; Riesgo RDS
Neuroimmunomodulation; 2018; 25(5-6):300-319. PubMed ID: 30184549
[TBL] [Abstract][Full Text] [Related]
10. ω-3 Fatty Acid Supplementation Does Not Affect Autism Spectrum Disorder in Children: A Systematic Review and Meta-Analysis.
Horvath A; Łukasik J; Szajewska H
J Nutr; 2017 Mar; 147(3):367-376. PubMed ID: 28077731
[No Abstract] [Full Text] [Related]
11. Relationship between Long Chain n-3 Polyunsaturated Fatty Acids and Autism Spectrum Disorder: Systematic Review and Meta-Analysis of Case-Control and Randomised Controlled Trials.
Mazahery H; Stonehouse W; Delshad M; Kruger MC; Conlon CA; Beck KL; von Hurst PR
Nutrients; 2017 Feb; 9(2):. PubMed ID: 28218722
[TBL] [Abstract][Full Text] [Related]
12. Prednisolone as Adjunctive Treatment to Risperidone in Children With Regressive Type of Autism Spectrum Disorder: A Randomized, Placebo-Controlled Trial.
Malek M; Ashraf-Ganjouei A; Moradi K; Bagheri S; Mohammadi MR; Akhondzadeh S
Clin Neuropharmacol; 2020; 43(2):39-45. PubMed ID: 32168067
[TBL] [Abstract][Full Text] [Related]
13. Omega-3 fatty acids in the management of autism spectrum disorders: findings from an open-label pilot study in Singapore.
Ooi YP; Weng SJ; Jang LY; Low L; Seah J; Teo S; Ang RP; Lim CG; Liew A; Fung DS; Sung M
Eur J Clin Nutr; 2015 Aug; 69(8):969-71. PubMed ID: 25804268
[TBL] [Abstract][Full Text] [Related]
14. Minocycline and celecoxib as adjunctive treatments for bipolar depression: a multicentre, factorial design randomised controlled trial.
Husain MI; Chaudhry IB; Khoso AB; Husain MO; Hodsoll J; Ansari MA; Naqvi HA; Minhas FA; Carvalho AF; Meyer JH; Deakin B; Mulsant BH; Husain N; Young AH
Lancet Psychiatry; 2020 Jun; 7(6):515-527. PubMed ID: 32445690
[TBL] [Abstract][Full Text] [Related]
15. The effectiveness and adverse effects of D-cycloserine compared with placebo on social and communication skills in individuals with autism spectrum disorder.
Aye SZ; Ni H; Sein HH; Mon ST; Zheng Q; Wong YKY
Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013457. PubMed ID: 33583058
[TBL] [Abstract][Full Text] [Related]
16. Methylphenidate for children and adolescents with autism spectrum disorder.
Sturman N; Deckx L; van Driel ML
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011144. PubMed ID: 29159857
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D and omega-3 fatty acid supplements in children with autism spectrum disorder: a study protocol for a factorial randomised, double-blind, placebo-controlled trial.
Mazahery H; Conlon C; Beck KL; Kruger MC; Stonehouse W; Camargo CA; Meyer BJ; Tsang B; Mugridge O; von Hurst PR
Trials; 2016 Jun; 17(1):295. PubMed ID: 27334138
[TBL] [Abstract][Full Text] [Related]
18. Adjunctive use of anti-inflammatory drugs for schizophrenia: A meta-analytic investigation of randomized controlled trials.
Cho M; Lee TY; Kwak YB; Yoon YB; Kim M; Kwon JS
Aust N Z J Psychiatry; 2019 Aug; 53(8):742-759. PubMed ID: 30864461
[TBL] [Abstract][Full Text] [Related]
19. Dietary Interventions for Autism Spectrum Disorder: A Meta-analysis.
Fraguas D; Díaz-Caneja CM; Pina-Camacho L; Moreno C; Durán-Cutilla M; Ayora M; González-Vioque E; de Matteis M; Hendren RL; Arango C; Parellada M
Pediatrics; 2019 Nov; 144(5):. PubMed ID: 31586029
[TBL] [Abstract][Full Text] [Related]
20. Effect of Omega-3 and -6 Supplementation on Language in Preterm Toddlers Exhibiting Autism Spectrum Disorder Symptoms.
Sheppard KW; Boone KM; Gracious B; Klebanoff MA; Rogers LK; Rausch J; Bartlett C; Coury DL; Keim SA
J Autism Dev Disord; 2017 Nov; 47(11):3358-3369. PubMed ID: 28748334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
